ITGA2B and autoimmune thrombocytopenic purpura: The passive murine ITP model was elicited by intraperitoneally injected with anti-platelet monoclonal antibody (mAb, rat anti-mouse CD41) at an initial dose of 0.375 mg/kg body weight and follow up doses of 0.125 mg/kg every 36 hours.